Agriflu Market Report 2026

Agriflu Market Overview

• The Agriflu market growth in the historic period has been driven by recurring influenza outbreaks, public vaccination campaigns • Market expansion is supported by aging population growth, expansion of national vaccination schedules • Growth Driver: Rising Influenza Prevalence To Drive Growth In The Agriflu Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Agriflu Market?

Agiflu is a seasonal influenza vaccine designed to protect against the flu virus. It is typically an inactivated, quadrivalent vaccine that helps the immune system recognize and fight off influenza viruses. The main indications for agriflu are avian influenza (bird flu), foot and mouth disease (fmd), classical swine fever (CSF), other indications. Avian influenza, also known as bird flu, is a viral infection that primarily affects birds, particularly wild birds, domestic poultry (such as chickens, ducks, and turkeys), and other avian species. The various route of administration include injectable vaccines, and nasal spray vaccines. These are distributed through various distribution channels such as hospitals and clinics, retail and specialty pharmacies, government and institutional supply.

What Is The Agriflu Market Growth Forecast?

The growth in the forecast period can be attributed to aging population growth, expansion of national vaccination schedules, rising healthcare spending, advancements in vaccine formulation, increasing pandemic preparedness initiatives. Major trends in the forecast period include rising demand for seasonal influenza vaccination, expansion of quadrivalent vaccine adoption, increased focus on preventive healthcare, growth of government immunization programs, improved cold chain vaccine distribution.

Global Agriflu Market Segmentation

1) By Clinical Indication: Avian Influenza (Bird Flu), Foot and Mouth Disease (FMD), Classical Swine Fever (CSF), Other Indications 2) By Route Of Administration: Injectable Vaccines, Nasal Spray Vaccines 3) By Distribution Channel: Hospitals And Clinics, Retail And Specialty Pharmacies, Government And Institutional Supply

What Are The Drivers Of The Agriflu Market?

The increasing prevalence of influenza cases is expected to propel the growth of the agriflu market going forward. Influenza, commonly known as the flu, is a contagious respiratory illness caused by influenza viruses. The rising prevalence of influenza is due to factors such as increased global travel, the mutation of the influenza virus into new strains, seasonal variations, limited immunity in populations, and insufficient vaccination coverage in certain regions. Agriflu provides targeted vaccination for poultry, helps mitigate the spread of avian influenza, reducing the risk of viral transmission between birds and to humans, thereby playing a crucial role in controlling outbreaks and preventing potential public health threats. For instance, in October 2023, according to the World Health Organization, a Switzerland-based health organization, there are around a billion cases of seasonal influenza annually, including 3–5 million cases of severe illness. Therefore, the increasing prevalence of influenza cases drives the agriflu industry. Government initiatives for research and development in healthcare are expected to propel the growth of the growth of the agriflu market going forward. Government initiatives refer to specific actions, programs, policies, or projects undertaken by government authorities at various levels (local, regional, national, or international) to address specific issues, achieve certain goals, or create positive changes in society. Several government authorities are initiating various healthcare initiatives to support various aspects including agriflu. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, reported that total healthcare expenditure saw a 5.6% increase in nominal terms from 2022 to 2023, marking a significant acceleration compared to the 0.9% growth observed in 2022. Therefore, the increasing government initiatives for research and development in healthcare drives the agriflu industry. Increasing immunization programs is expected to propel the growth of the agriflu market going forward. Immunization programs are structured public health initiatives designed to protect individuals and populations from infectious diseases by administering vaccines. The increasing immunization programs are due to the growing recognition of their effectiveness in preventing the spread of infectious diseases, the expansion of global vaccination coverage, advancements in vaccine technology, heightened awareness of public health risks, and the push for greater protection of vulnerable populations, including infants, elderly individuals, and those with compromised immune systems. Immunization programs provide targeted vaccination such as agriflu for poultry, thereby controlling the spread of avian influenza, reducing the risk of zoonotic transmission to humans, and contributing to broader public health efforts to prevent influenza outbreaks and protect both animal and human populations from the harmful effects of the virus. For instance, in January 2024, according to the National Health Service, a UK-based government agency, initiated NHS vaccine strategy for immunization goals. The strategy includes plans for community-based vaccination services, particularly targeting underserved and marginalized groups. Multidisciplinary teams will be deployed to improve access and outreach. Therefore, increasing immunization programs drives the agriflu industry.

Key Players In The Global Agriflu Market

Major companies operating in the agriflu market are Sanofi Pasteur S.A.

Regional Insights

North America was the largest region in the agriflu market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Agriflu Market?

The agiflu market consists of the sale of influenza vaccine therapies, including annual flu shots, nasal sprays, and other immunization treatments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Agriflu Market Report 2026?

The agriflu market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the agriflu industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.